-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Wednesday's After-Market Session
Share
Listen to the news

Gainers

  • Aditxt (NASDAQ:ADTX) stock moved upwards by 20.4% to $0.01 during Wednesday's after-market session.
  • Agape ATP (NASDAQ:ATPC) shares moved upwards by 17.21% to $3.2. The company's market cap stands at $2.8 million.
  • NeuroSense Therapeutics (NASDAQ:NRSN) stock moved upwards by 10.65% to $0.78. The market value of their outstanding shares is at $25.2 million.
  • Spero Therapeutics (NASDAQ:SPRO) stock increased by 8.53% to $2.29. The market value of their outstanding shares is at $160.3 million.
  • Dogwood Therapeutics (NASDAQ:DWTX) shares moved upwards by 6.04% to $1.58. The market value of their outstanding shares is at $50.4 million.
  • iSpecimen (NASDAQ:ISPC) stock increased by 5.49% to $2.69. The company's market cap stands at $3.7 million.

Losers

  • Eloxx Pharma (NASDAQ:ELOX) shares declined by 15.0% to $12.0 during Wednesday's after-market session. The market value of their outstanding shares is at $43.8 million.
  • Elicio Therapeutics (NASDAQ:ELTX) shares decreased by 14.44% to $4.03. The company's market cap stands at $52.6 million.
  • Rafael Holdings (NYSE:RFL) shares fell 14.07% to $2.26. The company's market cap stands at $132.0 million. The company's, Q3 earnings came out 4 days ago.
  • LeonaBio (NASDAQ:LONA) stock fell 11.31% to $7.3. The company's market cap stands at $74.0 million.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares decreased by 8.93% to $3.98. The company's market cap stands at $2.3 million.
  • Picard Medical (AMEX:PMI) stock declined by 8.38% to $0.17. The company's market cap stands at $15.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending